Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment

Molecular Biology and Evolution

Volumn 24, Issue 8, 2007, Pages 1582-1585

  Musset, Lise ^a,b   Le Bras, Jacques ^a,b   Clain, Jérôme ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Atovaquone proguanil resistance; Cytochrome b; Parallel evolution; Plasmodium falciparum

Indexed keywords

ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; CYTOCHROME B; MITOCHONDRIAL DNA; PROTOZOAL DNA;

ALLELE; ARTICLE; CODON; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HAPLOTYPE; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; TREATMENT FAILURE;

ANIMALS; ANTIMALARIALS; ATOVAQUONE; BASE SEQUENCE; CHLOROGUANIDE; CYTOCHROMES B; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; DRUG RESISTANCE; EVOLUTION; HUMANS; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; MUTATION; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; SEQUENCE HOMOLOGY, NUCLEIC ACID;

PLASMODIUM FALCIPARUM;

EID: 34547757436     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msm087     Document Type: Article

References (25)

1. Anderson TJ, Roper C. 2005. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop. 94:269-280.
2. Ariey F, Fandeur T, Durand R, et al. (13 co-authors). 2006. Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J. 5:34.
3. Boucher CA, O'Sullivan E, Mulder JW, Ramautarsing C, Kellam P, Darby G, Lange JM, Goudsmit J, Larder BA. 1992. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency viruspositive subjects. J Infect Dis. 165:105-110.
4. Colosimo PF, Hosemann KE, Balabhadra S, Villarreal G Jr, Dickson M, Grimwood J, Schmutz J, Myers RM, Schluter D, Kingsley DM. 2005. Widespread parallel evolution in sticklebacks by repeated fixation of Ectodysplasin alleles. Science. 307:1928-1933.
5. Cortese JF, Caraballo A, Contreras CE, Plowe CV. 2002. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis. 186:999-1006.
6. Cunningham CW, Jeng K, Husti J, Badgett M, Molineux IJ, Hillis DM, Bull JJ. 1997. Parallel molecular evolution of deletions and nonsense mutations in bacteriophage T7. Mol Biol Evol. 14:113-116.
7. Fivelman QL, Adagu IS, Warhurst DC. 2004. Modified fixedratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother. 48:4097-4102.
8. Gassis S, Rathod PK. 1996. Frequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance. Antimicrob Agents Chemother. 40:914-919.
9. Hastings IM. 2004. The origins of antimalarial drug resistance. Trends Parasitol. 20:512-518.
10. Inoue K, Lupski JR. 2002. Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet. 3:199-242.
11. Joy DA, Feng X, Mu J, Furuya T, et al. (12 co-authors). 2003. Early origin and recent expansion of Plasmodium falciparum. Science. 300:318-321.
12. Kessl JJ, Ha KH, Merritt AK, Lange BB, Hill P, Meunier B, Meshnick SR, Trumpower BL. 2005. Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae. J Biol Chem. 280:17142-17148.
13. Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K, Cheng Q. 2000. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother. 44:2100-2108.
14. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ. 1996. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg. 54:62-66.
15. Musset L, Bouchaud O, Matheron S, Massias L, Le Bras J. 2006. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. Microb Inf. 8:2599-2604.
16. Nair S, Williams JT, Brockman A, et al. (12 co-authors). 2003. A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. Mol Biol Evol. 20:1526-1536.
17. Nair S, Nash D, Sudimack D, Jaidee A, Barends M, Uhlemann AC, Krishna S, Nosten F, Anderson TJ. 2007. Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. Mol Biol Evol. 24:562-573.
18. Pennings PS, Hermisson J. 2006a. Soft sweeps II - molecular population genetics of adaptation from recurrent mutation or migration. Mol Biol Evol. 23:1076-1084.
19. Pennings PS, Hermisson J. 2006b. Soft sweeps III: the signature of positive selection from recurrent mutation. PLoS Genet. 2:e186.
20. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, Chandramohan D, Sharp B. 2003. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet. 361:1174-1181.
21. Schwartz E, Bujanover S, Kain KC. 2003. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa. Clin Infect Dis. 37:450-451.
22. Wichman HA, Badgett MR, Scott LA, Boulianne CM, Bull JJ. 1999. Different trajectories of parallel evolution during viral adaptation. Science. 285:422-424.
23. Wichman HA, Scott LA, Yarber CD, Bull JJ. 2000. Experimental evolution recapitulates natural evolution. Philos Trans R Soc Lond B Biol Sci. 355:1677-1684.
24. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 418:320-323.
25. Zhang J, Kumar S. 1997. Detection of convergent and parallel evolution at the amino acid sequence level. Mol Biol Evol. 14:527-536.